Summary
The aim of this study was to evaluate whether long-term glucose control, as assessed by fasting plasma glucose determinations during 3 years, is a predictor of all-cause mortality in elderly NIDDM patients. Five hundred and sixty-six NIDDM patients attending the Verona Diabetes Clinic, aged 75 years and over, were followed-up from 1 January 1987 to 31 December 1991 to assess all-cause mortality. From their clinical records all fasting plasma glucose determinations available for the years 1984 to 1986 were collected and analysed. Patients were grouped in tertiles according to mean (M-FPG), coefficient of variation (CV-FPG) and trend over time (slope, S-FPG) of fasting plasma glucose during the period of retrospective evaluation. Mortality was assessed by observed/expected ratios, univariate Kaplan-Meier survival analysis and multivariate Poisson regression model. By 31 December 1991, 61 men and 127 women had died. Increased observed/expected ratios were found in women from the top M-FPG tertile, in patients (men and women) from the top CV-FPG tertile and in patients with a S-FPG less than −0.30 mmol/l per year (lowest tertile). Patients in the lowest tertile of CV-FPG and in the middle tertile of S-FPG had a reduced mortality risk. Kaplan-Meier survival analysis indicated that patients with high CV-FPG as well as those in tertiles I and III of S-FPG (i.e., those with a definitely negative or definitely positive slope) had an increased probability of dying, without any significant differences between the three tertiles of M-FPG. Poisson regression model showed that CV-FPG, but not M-FPG or S-FPG, was an independent significant predictor of mortality. These results suggest that glucose stability needs to be considered along with the absolute level of metabolic control when treating elderly NIDDM patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- SHU:
-
Social Health Unit
- M-FPG:
-
mean fasting plasma glucose
- CV-FPG:
-
coefficient of variation of fasting plasma glucose
- S-FPG:
-
slope of fasting plasma glucose over time
References
Harris MI, Hadden WC, Knowler WC, Bennet PH (1987) Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U. S. population aged 20–74 yr. Diabetes 36: 523–534
Neil HAW, Gatling W, Mather HM et al. (1987) The Oxford Community Diabetes Study: evidence for an increase in the prevalence of known diabetes in Great Britain. Diabet Med 4: 539–543
Damsgaard EM, Faber OK, Froland A, Green A, Hauge M, Holm NV, Iversen S (1987) Prevalence of fasting hyperglycaemia and known non-insulin-dependent diabetes mellitus classified by plasma C-peptide. Diabetes Care 10: 26–32
Croxon SCM, Burden AC, Bodington M, Botha JL (1991) The prevalence of diabetes in elderly people. Diabet Med 8: 28–31
Bruno G, Bargero G, Vuolo A, Pisu E, Pagano G (1992) A population-based prevalence survey of known diabetes mellitus in Northern Italy based upon multiple independent sources of ascertainment. Diabetologia 35: 851–856
Muggeo M, Verlato G, Bonors E et al. (1995) The Verona Diabetes Study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia 38: 318–325
Cohen DL, Neil H, Thorogood M, Mann JI (1991) A population-based study of the incidence of complications associated with type 2 diabetes in the elderly. Diabet Med 8: 928–933
Halter JB (1994) Geriatric patients. In: Lebovitz HE (ed) Therapy for diabetes mellitus and related disorders, 2nd edn. American Diabetes Association, Alexandria, VA, USA, pp 164–169
Kleinmann JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB (1988) Mortality among diabetics in a national sample. Am J Epidemiol 128: 389–401
Stengard JH, Tuomilehto J, Pekkanen J et al. (1992) Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: the Finnish cohorts of the Seven Countries Study. Diabetologia 35: 760–765
Entmacher PS, Sinnock P, Bostic E, Harris MI (1985) Economic impact of diabetes. In: National Diabetes Data Group (ed) Diabetes in America; NIH Publication No. 85-1468, pp XXXII.1–13
National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057
Coleman M, Douglas A, Hermon C, Peto J (1986) Cohort study analysis with a Fortran computer program. Int J Epidemiol 15: 134–137
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481
Clayton D, Hills M (1993) Statistical models in epidemiology. Oxford Science Publication, Oxford (UK)
Snedecor GW, Cochran WG (1967) Statistical methods. Ames Iowa, Iowa State University Press
Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K (1993) Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36: 1175–1184
Fuller JH, Elford J, Goldblatt P, Adelstein AM (1983) Diabetes mortality: New light on an underestimated public health problem. Diabetologia 24: 336–341
Fuller JH (1994) Mortality from diabetes. In: Williams R, Papoz L, Fuller JH (eds) Diabetes in Europe. Libbey, London, pp 108–116
UK Prospective Diabetes Study Group (1991) UK prospective diabetes study (UKPDS). VIII. Study design, progress and performance. Diabetologia 34: 877–890
Abraira C, Emanuele N, Colwell J, Henderson W, Comstock J, Lvin S, Nuttal F, Sawin C, VACS Group (1992) Glycaemic control and complications in type II diabetes: design of the feasibility trial. Diabetes Care 15: 1560–1571
Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986
Reichard P, Nilsson BY, Rosenqvist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329: 304–309
Raskin P, Rosenstock J (1986) Blood glucose control and diabetic complications. Ann Intern Med 105: 254–263
Liu QZ, Pettitt DJ, Hanson RL, Charles MA, Klein R, Bennett PH, Knowler WC (1993) Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses. Diabetologia 36: 428–432
Wilson RM (1991) Infections and diabetes mellitus. In: Pickup J, Williams G (eds) Textbook of diabetes. Blackwell Scientific Publications, Oxford, pp 813–819
Gill GV (1991) Surgery and diabetes mellitus. In: Pickup J, Williams G (eds) Textbook of diabetes. Blackwell Scientific Publications, Oxford, pp 820–826
Frier BM (1993) Hypoglycemia in the diabetic adult. Clin Endocrinol Metab 7: 757–777
Jarrett RJ (1988) Is insulin atherogenic? Diabetologia 31: 71–75
Janka HU, Ziegler AG, Standl E, Mehnert H (1987) Daily insulin dose as a predictor of macrovascular disease in insulin treated non-insulin-dependent diabetics. Diabete Metabol 13: 359–364
Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K (1990) 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin levels, and abnormalities in lipoprotein composition in non-insulin-dependent diabetes and non-diabetic subjects. Circulation 82: 27–36
Eastman RC, Siebert CS, Harris M, Gorden P (1993) Clinical Review 51. Implications of the Diabetes Control and Complications Trial. J Clin Endocrinol Metab 77: 1105–1107
Lebovitz HE (1994) The DCCT and its implications for NIDDM. Clinical Diabetes 12: 3–4
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Muggeo, M., Verlato, G., Bonora, E. et al. Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients: the Verona Diabetes Study. Diabetologia 38, 672–679 (1995). https://doi.org/10.1007/BF00401838
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00401838